Area of research
Genetics · Surgery
Research interest
Research interests include Diabetes and associated disorders, Pancreatic function and diabetes, Diabetes Management and Research, and Microbial Community Ecology and Physiology.
IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes
Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial
Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes
Comparative genome-scale modelling of <i>Staphylococcus aureus</i> strains identifies strain-specific metabolic capabilities linked to pathogenicity
“Every Gene Is Everywhere but the Environment Selects”: Global Geolocalization of Gene Sharing in Environmental Samples through Network Analysis
M<scp>e</scp>D<scp>u</scp>S<scp>a</scp>: a multi-draft based scaffolder